Edesa Biotech (EDSA) Current Assets (2013 - 2026)

Edesa Biotech has disclosed Current Assets across 14 years of filings, most recently posting $10.8 million for Q2 2026.

• In Q2 2026, Current Assets fell 15.52% year-over-year to $10.8 million; the TTM figure through Jun 2026 stood at $10.8 million (down 15.52% YoY), while the FY2025 annual figure was $11.5 million, up 587.08% from the prior year.
• Current Assets came in at $10.8 million for Q2 2026 at Edesa Biotech, down from $12.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $18.0 million in Q1 2022 to a low of $1.7 million in Q3 2024.
• Average Current Assets over 5 years is $8.9 million, with a median of $9.1 million recorded in 2022.
• Year-over-year, Current Assets sank 73.97% in 2024 and soared 587.08% in 2025.
• Over 5 years, Current Assets stood at $9.1 million in 2022, then tumbled by 40.39% to $5.4 million in 2023, then slumped by 61.75% to $2.1 million in 2024, then soared by 513.8% to $12.7 million in 2025, then decreased by 15.23% to $10.8 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $10.8 million in Q2 2026, $12.7 million in Q4 2025, and $11.5 million in Q3 2025.